273 related articles for article (PubMed ID: 12881473)
1. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
Husain A; Li M; Graham RM
Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
[No Abstract] [Full Text] [Related]
2. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
3. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
Liao Y; Husain A
Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
[TBL] [Abstract][Full Text] [Related]
4. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
[TBL] [Abstract][Full Text] [Related]
5. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart.
Katugampola SD; Davenport AP
Clin Sci (Lond); 2002 Jan; 102(1):15-21. PubMed ID: 11749656
[TBL] [Abstract][Full Text] [Related]
6. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
[TBL] [Abstract][Full Text] [Related]
7. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum.
Iwamoto Y; Song K; Takai S; Yamada M; Jin D; Sakaguchi M; Ueda H; Katsuoka Y; Miyazaki M
J Pharmacol Exp Ther; 2001 Jul; 298(1):43-8. PubMed ID: 11408523
[TBL] [Abstract][Full Text] [Related]
8. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C
Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696
[TBL] [Abstract][Full Text] [Related]
9. Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: a functional and biochemical study.
Waldeck K; Lindberg BF; Persson K; Andersson KE
Br J Pharmacol; 1997 Jul; 121(6):1081-6. PubMed ID: 9249242
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension.
Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J
J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764
[TBL] [Abstract][Full Text] [Related]
11. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
[TBL] [Abstract][Full Text] [Related]
12. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
[TBL] [Abstract][Full Text] [Related]
13. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation.
Li M; Liu K; Michalicek J; Angus JA; Hunt JE; Dell'Italia LJ; Feneley MP; Graham RM; Husain A
J Clin Invest; 2004 Jul; 114(1):112-20. PubMed ID: 15232618
[TBL] [Abstract][Full Text] [Related]
14. Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms?
Kokkonen JO; Lindstedt KA; Kovanen PT
Circulation; 2003 May; 107(20):2522-4. PubMed ID: 12777313
[No Abstract] [Full Text] [Related]
15. Development of domain-selective angiotensin I-converting enzyme inhibitors.
Redelinghuys P; Nchinda AT; Sturrock ED
Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
[TBL] [Abstract][Full Text] [Related]
17. The functional ratio of chymase and angiotensin converting enzyme in angiotensin I-induced vascular contraction in monkeys, dogs and rats.
Jin D; Takai S; Yamada M; Sakaguchi M; Miyazaki M
Jpn J Pharmacol; 2000 Dec; 84(4):449-54. PubMed ID: 11202618
[TBL] [Abstract][Full Text] [Related]
18. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.
Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK
Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828
[TBL] [Abstract][Full Text] [Related]
19. [Role of angiotensin II-forming enzymes, angiotensin-converting enzyme and chymase].
Takai S; Miyazaki M
Nihon Rinsho; 1999 May; 57(5):1078-83. PubMed ID: 10361438
[TBL] [Abstract][Full Text] [Related]
20. ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?
Tom B; Garrelds IM; Scalbert E; Stegmann AP; Boomsma F; Saxena PR; Danser AH
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):251-6. PubMed ID: 12588767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
